The effects of 5-aminoimidazole-4-carboxamide riboside on the pancreas in neonatal streptozotocin-diabetic rats

Acta Diabetologica

Volumn 43, Issue 3, 2006, Pages 61-65

  Ozturk, M ^a   Bolkent, S ^a   Kaya Dagistanli, F ^a   Tuncdemir, M ^a   Yilmazer, S ^a   Akkan, A G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

AICAR; Beta cell; Neonatal diabetes; Rat

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; EXOCYTOSIS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN SYNTHESIS; LONG TERM CARE; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT GAIN;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; PANCREAS; RATS; RIBONUCLEOTIDES; RNA, MESSENGER;

EID: 33845318887     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-006-0214-6     Document Type: Article

References (27)

1. Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-Aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558-565
2. Merrill GF, Kurth EJ, Hardie DG, Winder WW (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273:1107-1112
3. Winder WW (2000) AMP-activated protein kinase: possible target for treatment of type 2 diabetes. Diabetes Technol Ther 2:441-448
4. Mu J, Barton ER, Birnbaum MJ (2003) Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem Soc Trans 31:236-241
5. Kefas BA, Heimberg H, Vaulont S, Meisse D, Hue L, Pipeleers D, Van de Casteele M (2003) AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 46:250-254
6. Nissim I, Yudkoff M, Nissim I, States B (1989) Effect of 5-amino-4-imidazolecarboxamide riboside (AICA-riboside) on the purine nucleotide synthesis and growth of rat kidney cells in culture: study with [15N]aspartate. J Cell Physiol 138:536-540
7. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW (2003) AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats Diabetes 52:223-224
8. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S (2003) Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94:1373-1379
9. Salt IP, Connell JM, Gould GW (2000) 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49:1649-1656
10. Dixon R, Gourzis J, McDermott D, Fujitaki J, Dewland P, Gruber H (1991) AICA-riboside: safety, tolerance, and pharmacokinetics of a novel adenosine-regulating agent. J Clin Pharmacol 31:342-347
11. Portha B, Blondel O, Serradass P, McEvoy R, Giroix MH, Kergoit M, Bailbe D (1989) The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab 15:61-75
12. Akkan AG, Malaisse WJ (1994) Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Res 25:13-23
13. Malaisse WJ, Conget I, Sener A, Rorsman P (1994) Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Diabetes Res 25:25-37
14. Salt IP, Johnson G, Ashcroft SJ, Hardie DG (1998) AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J 335:533-539
15. Wang CZ, Wang Y, Di A, Magnuson MA, Ye H, Roe MW, Nelson DJ, Bell GI, Philipson LH (2005) 5-Amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochem Biophys Res Commun 20:1073-1079
16. Bolkent S, Yilmazer S (1997) Alterations in gastrin cells induced by short-term omeprazole treatment in the rat antrum: an immunocytochemical and in situ hybridization study. Histochem J 29:479-485
17. Ferrand N, Astesano A, Phan H, Lelong C, Rosselin G (1995) Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats. Am J Physiol 369:C1250-C1264
18. Boner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin limited B-cell regeneration and hyperglycemia. Diabetes 30:64-69
19. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S (2005) Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54:928-934
20. Bonner-Weir S (2001) Beta-cell turnover: its assessment and implications. Diabetes. 50[Suppl 1]:S20-24
21. Waguri M, Yamamato K, Miyagawa J, Tochino Y, Yamamori K, Kajimato Y (1997) Demonstration of two different processes of B cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. Diabetes 46:1281-1290
22. Kowluru A, Chen HQ, Modrick LM, Stefanelli C (2001) Activation of acetyl-CoA carboxylase by a glutamate- and magnesium-sensitive protein phosphatase in the islet beta-cell. Diabetes 50:1580-1587
23. Leclerc I, Lenzner C, Gourdon L, Vaulont S, Kahn A, Viollet B (2001) Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50:1515-1521
24. Young ME, Radda GK, Leighton B (1996) Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase. FEBS Lett 382:43-47
25. Song XM, Fiedler M, Galuska D, Ryder JW, Fernstrom M, Chibalin AV, Wallberg-Henriksson H, Zierath JR (2002) 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) ice. Diabetologia 45:56-65
26. Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA (2002) Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun 294:798-805
27. Musi N, Goodyear LJ (2002) Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2:119-127